BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21848963)

  • 1. Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial.
    Rombout-Sestrienkova E; Nieman FH; Essers BA; van Noord PA; Janssen MC; van Deursen CT; Bos LP; Rombout F; van den Braak R; de Leeuw PW; Koek GH
    Transfusion; 2012 Mar; 52(3):470-7. PubMed ID: 21848963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocytapheresis versus phlebotomy in the maintenance treatment of HFE hemochromatosis patients: results from a randomized crossover trial.
    Rombout-Sestrienkova E; Winkens B; Essers BA; Nieman FH; Noord PA; Janssen MC; van Deursen CT; Boonen A; Reuser-Kaasenbrood EP; Heeremans J; van Kraaij M; Masclee A; Koek GH
    Transfusion; 2016 Jan; 56(1):261-70. PubMed ID: 26358375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison between phlebotomy and erythrocytapheresis of iron overload in patients with HFE gene mutations].
    Fernández-Mosteirín N; Salvador-Osuna C; García-Erce JA; Orna E; Pérez-Lungmus G; Giralt M
    Med Clin (Barc); 2006 Sep; 127(11):409-12. PubMed ID: 17020684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis - A pilot study.
    Rombout-Sestrienkova E; van Noord PA; van Deursen CT; Sybesma BJ; Nillesen-Meertens AE; Koek GH
    Transfus Apher Sci; 2007 Jun; 36(3):261-7. PubMed ID: 17569592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of iron parameters in HFE-hemochromatosis patients during initial treatment with erythrocytapheresis compared to phlebotomy.
    Rombout-Sestrienkova E; Koek GH; Neslo R; van Kraaij M; Menheere PP; Masclee A; Swinkels DW
    J Clin Apher; 2016 Dec; 31(6):564-570. PubMed ID: 26878994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis.
    Rombout-Sestrienkova E; Winkens B; van Kraaij M; van Deursen CTBM; Janssen MCH; Rennings AMJ; Evers D; Kerkhoffs JL; Masclee A; Koek GH
    J Clin Apher; 2021 Jun; 36(3):340-347. PubMed ID: 33368569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron).
    Ong SY; Dolling L; Dixon JL; Nicoll AJ; Gurrin LC; Wolthuizen M; Wood EM; Anderson GJ; Ramm GA; Allen KJ; Olynyk JK; Crawford D; Kava J; Ramm LE; Gow P; Durrant S; Powell LW; Delatycki MB
    BMJ Open; 2015 Aug; 5(8):e008938. PubMed ID: 26270952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.
    Ong SY; Gurrin LC; Dolling L; Dixon J; Nicoll AJ; Wolthuizen M; Wood EM; Anderson GJ; Ramm GA; Allen KJ; Olynyk JK; Crawford D; Ramm LE; Gow P; Durrant S; Powell LW; Delatycki MB
    Lancet Haematol; 2017 Dec; 4(12):e607-e614. PubMed ID: 29195602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythrocytapheresis for hereditary haemochromatosis].
    Rombout-Sestrienkova E; van Deursen CT; Janssen MC; van Kraaij MG; de Leeuw PW; Koek GH
    Ned Tijdschr Geneeskd; 2012; 156(26):A4745. PubMed ID: 22759710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of therapeutic erythrocytapheresis to achieve iron depletion in hereditary type 1 hemochromatosis: report of 30 cases].
    Poullin P; Lefèvre PA
    Transfus Clin Biol; 2011 Dec; 18(5-6):553-8. PubMed ID: 22019606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocytapheresis plus erythropoietin: an alternative therapy for selected patients with hemochromatosis and severe organ damage.
    Mariani R; Pelucchi S; Perseghin P; Corengia C; Piperno A
    Haematologica; 2005 May; 90(5):717-8. PubMed ID: 15921401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
    Phatak PD; Barton JC
    Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Pump Inhibitors Reduce the Frequency of Phlebotomy in Patients With Hereditary Hemochromatosis.
    van Aerts RM; van Deursen CT; Koek GH
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):147-52. PubMed ID: 26240005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of hereditary hemochromatosis: an update.
    Kanwar P; Kowdley KV
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):517-30. PubMed ID: 23985001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study.
    Milet J; Le Gac G; Scotet V; Gourlaouen I; Thèze C; Mosser J; Bourgain C; Deugnier Y; Férec C
    Blood Cells Mol Dis; 2010 Jan; 44(1):34-7. PubMed ID: 19879168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary hemochromatosis: missed diagnosis or misdiagnosis?
    Cherfane CE; Hollenbeck RD; Go J; Brown KE
    Am J Med; 2013 Nov; 126(11):1010-5. PubMed ID: 24054178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.